NYSE : LLY

Eli Lilly and Company — Key statistics

Healthcare · Drug Manufacturers - General · United States

Last price 1373.7 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.22T

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

MeasureValue
Market Cap1.26T
Enterprise Value1.31T

Dates

MeasureValue
Earnings DateOct 29, 2026
Ex-Dividend DateNov 13, 2026

Shares

MeasureValue
Current Share Class890.75M
Shares Outstanding890.75M
Shares Change (YoY)-0.58%
Shares Change (QoQ)-0.03%
Owned by Insiders (%)0.17%
Owned by Institutions (%)89.43%
Float888.34M

Ratios

MeasureValue
PE Ratio46.01
Forward PE30.50
PS Ratio14.60
Forward PS12.81
PB Ratio31.37
P/TBV Ratio102.55
P/FCF Ratio64.22
P/OCF Ratio41.20
PEG Ratio1.47

Evratios

MeasureValue
EV / Earnings47.37
EV / Sales15.11
EV / EBITDA28.10
EV / EBIT29.48
EV / FCF66.45

Financialposition

MeasureValue
Current Ratio1.39
Quick Ratio0.64
Debt / Equity1.23
Debt / EBITDA1.06
Debt / FCF2.52
Interest Coverage115.70

Financialefficiency

MeasureValue
Return on Equity (ROE)86.02%
Return on Assets (ROA)21.06%
Return on Invested Capital (ROIC)42.68%
Return on Capital Employed (ROCE)43.84%
Weighted Average Cost of Capital (WACC)6.51%
Revenue Per Employee$1.73M
Profits Per Employee$551,600
Employee Count50,000
Asset Turnover0.66
Inventory Turnover0.93

Taxes

MeasureValue
Income Tax7.19B
Effective Tax Rate20.68%

Stockprice

MeasureValue
Beta (5Y)0.45
52-Week Price Change+74.25%
50-Day Moving Average1,197.14
200-Day Moving Average1,091.24
Relative Strength Index (RSI)77.88
Average Volume (20 Days)2,525,129

Shortselling

MeasureValue
Short Interest6.96M
Short Previous Month7.52M
Short % of Shares Out0.78%
Short % of Float0.78%
Short Ratio (days to cover)3.00

Incomestatement

MeasureValue
Revenue86.46B
Gross Profit72.31B
Operating Income44.32B
Pretax Income34.77B
Net Income27.58B
EBITDA46.49B
EBIT44.32B
Earnings Per Share (EPS)$30.81

Balancesheet

MeasureValue
Cash & Cash Equivalents4.89B
Total Debt49.50B
Net Cash-43.86B
Net Cash Per Share-$49.24
Equity (Book Value)40.27B
Book Value Per Share45.19
Working Capital18.27B

Cashflow

MeasureValue
Operating Cash Flow30.65B
Capital Expenditures-10.98B
Depreciation & Amortization2.17B
Net Borrowing7.32B
Free Cash Flow19.66B
FCF Per Share$22.07

Margins

MeasureValue
Gross Margin83.63%
Operating Margin51.25%
Pretax Margin40.21%
Profit Margin31.90%
EBITDA Margin53.77%
EBIT Margin51.25%
FCF Margin22.74%

Dividends

MeasureValue
Dividend Per Share$6.92
Dividend Yield0.49%
Dividend Growth (YoY)15.33%
Years of Dividend Growth11
Payout Ratio22.46%
FCF Payout Ratio31.35%
Buyback Yield0.58%
Shareholder Yield1.07%
Earnings Yield2.17%
FCF Yield1.56%

Analystforecasts

MeasureValue
Price Target$1,421.06
Price Target Difference0.25%
Analyst ConsensusBuy
Analyst Count31
Revenue Growth Forecast (3Y)21.52%
EPS Growth Forecast (3Y)32.78%

Stocksplits

MeasureValue
Last Split DateOct 16, 1997
Split TypeForward
Split Ratio2:1

Scores

MeasureValue
Altman Z-Score7.27
Piotroski F-Score6

Fairvalue

MeasureValue
Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside